Transmission-blocking vaccine
Global genetic diversity of the Plasmodium vivax transmission blocking vaccine candidate Pvs48/45
... that transmission-blocking vaccine candidate antigens Pvs25, Pvs28, Pvs48/45, and PvWARP showed limited sequence polymorphisms ...a transmission-blocking vaccine ...
9
Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission blocking vaccine candidate
... A transmission-blocking vaccine (TBV) targeting the sexual stages of the Plasmodium has the potential to reduce malaria transmission and prevent the spread of resistant ...
11
Antigenic repertoire of Plasmodium vivax transmission blocking vaccine candidates from the Indian subcontinent
... in transmission-blocking vaccine candi- dates has been reported from various malaria endemic countries such as South and Central America [14-17], Iran [18], Korea [19], Bangladesh [15] and Southeast ...
7
N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate
... ABSTRACT Transmission-blocking vaccines have the potential to accelerate malaria parasite elimination by inducing antibodies that block parasite transmission from hu- mans to ...a ...
14
Asymptomatic Plasmodium vivax parasitaemia in the low transmission setting: the role for a population based transmission blocking vaccine for malaria elimination
... ongoing transmission through relapsed infections and asymptomatic infections, especially as chloroquine- resistant ...reduce transmission from both latently and subclinically low- level parasitaemic ...
7
Characterization of a Plasmodium berghei sexual stage antigen PbPH as a new candidate for malaria transmission blocking vaccine
... In this study, we showed that pbph is a highly conserved Plasmodium gene and PbPH protein localized it on the surface of gametes, zygotes, retorts and ookinetes. Func- tional studies of PbPH revealed that knockout of the ...
11
The Pfs230 N terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission blocking vaccine candidate
... parasite transmission [1–3] and likely to be preferentially deployed in combination with other antigens targeting other life cycle stages [4, ...thereby blocking the parasite fertilization after an ...
13
Plasmodium Sexual Stage Parasites Present Distinct Targets for Malaria Transmission-Blocking Vaccine Design
... multi-stage vaccine candidate named NYVAC-Pf7 [30]; however, immunogenicity was poor and no transmission-blocking activity by immune sera was detected in the membrane feeding assay that is used to ...
6
Genetic diversity of transmission blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China
... Many malaria parasite antigens display extensive genetic diversity as a result of host immune selection. Genetic polymorphisms in vaccine candidates hamper vaccine de- velopment, since they tend to elicit ...
11
Genetic diversity of transmission blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China
... The transmission-blocking assays conducted in Thailand clearly demonstrated that antisera to recombinant Pvs25 and Pvs28 based on the Sal-I strain of ...
8
Limited sequence polymorphisms of four transmission blocking vaccine candidate antigens in Plasmodium vivax Korean isolates
... natural parasite populations. Several studies have shown that TBV candidates have limited polymorphism com- pared to blood stage vaccine candidate antigens [14,33,34,45]. Since blood stage antigens are targets of ...
7
Sequence Polymorphism in Two Novel Plasmodium vivax Ookinete Surface Proteins, Pvs25 and Pvs28, That Are Malaria Transmission-blocking Vaccine Candidates
... Deduced amino acid sequence align- ment of the repeat region at the end of the fourth EGF-like domain of Pvs28 with the other P21/28 subfamily members. 28con represents the consensus ami[r] ...
11
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission blocking vaccine candidates
... The authors thank Ashley Birkett of MVI for his support and assistance in conceptualization of the work presented here. The authors would like to thank David Narum and Patrick Duffy, of the Laboratory of Malaria ...
12
Expression of full-length Plasmodium falciparum P48/45 in P. berghei blood stages: A method to express and evaluate vaccine antigens
... The transmission-blocking vaccine candidate Pfs48/45 from the human malaria parasite Plasmodium falciparum is known to be di ffi cult to express in heterologous systems, either as full-length protein ...
6
Plasmodium P25 and P28 Surface Proteins: Potential Transmission-Blocking Vaccines
... Several transmission-blocking vaccine formulations are be- ing developed using Plasmodium vivax and ...I vaccine trial of Pvs25 bound to aluminum hydroxide, the levels of antibodies that were ...
6
Acceptability of a herd immunity focused, transmission blocking malaria vaccine in malaria endemic communities in the Peruvian Amazon: an exploratory study
... focused, transmission-blocking malaria vaccine that does not directly protect recipients against malaria infection, we found that members of six malaria-hypoendemic communities in the Amazon River ...
12
Transmission blocking strategies: the roadmap from laboratory bench to the community
... of transmission-blocking ...a transmission blocking vaccine, and drugs are being currently screened for gametocytocidal activity, and also some new and less conventional approaches are ...
13
Fault blocking converters for HVDC transmission : a transient behaviour comparison
... DC blocking capability are an attractive solution due to their ability to quickly recover from DC-side ...with blocking capability: namely the Full-Bridge MMC (FB-MMC) and the Mixed-Cell MMC (MC-MMC)[5], ...
6
6085.pdf
... PR0 2000 was a naphthalene sulfonate polymer containing gel developed by Interneuron. This polyanionic compound had been shown to bind directly to the HIV gp120 protein and interfere with viral attachment/fusion [73]. In ...
131
A novel model fitted to multiple life stages of malaria for assessing efficacy of transmission blocking interventions
... using vaccine. This can be used directly in mathematical models to understand the epidemiology of diseases. Con- versely the Bayesian method directly calculates the reduc- tion in the prevalence and density of ...
10